日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies

针对妇科恶性肿瘤的白蛋白紫杉醇/贝伐单抗(AB160)纳米免疫偶联物治疗 I 期临床试验

Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Becher, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliam

Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts

丝氨酸蛋白酶尿激酶抑制剂Upamostat和鞘氨醇激酶2抑制剂Opaganib联合抗肿瘤作用对胆管癌患者来源异种移植瘤的影响

Asumda, Faizal Z; Campbell, Nellie A; Hassan, Mohamed A; Fathi, Reza; Vasquez Rico, Daniella F; Kiem, Melanie; Vang, Ethan V; Kim, Yo Han; Luo, Xin; O'Brien, Daniel R; Buhrow, Sarah A; Reid, Joel M; Moore, Michael J; Ben-Yair, Vered Katz; Levitt, Mark L; Leiting, Jennifer L; Abdelrahman, Amro M; Zhu, Xinli; Lucien, Fabrice; Truty, Mark J; Roberts, Lewis R

Previously Uncharacterized Variants, OCF-E-OCF-J, of the Antifungal Occidiofungin Produced by Burkholderia contaminans MS14

伯克霍尔德菌 MS14 产生的抗真菌药 Occidiofungin 的未鉴定变体 OCF-E-OCF-J

Nopakorn Hansanant, Kevin Cao, Abraham Tenorio, Thushinari Joseph, Min Ju, Noah McNally, Evangel Kummari, McKinley Williams, Andrew Cothrell, Andrew R Buhrow, Ronald Shin, Ravi Orugunty, Leif Smith

Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism

雌性大鼠和犬体内内多昔芬的生物利用度和药代动力学:支持使用内多昔芬克服CYP2D6介导的他莫昔芬代谢局限性的证据

Koubek, Emily J; Buhrow, Sarah A; Safgren, Stephanie L; Jia, Lee; Goetz, Matthew P; Ames, Matthew M; Reid, Joel M

A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia

一项针对复发和/或难治性急性淋巴细胞白血病患者的sapanisertib II期药理学研究

Al-Kali, Aref; Aldoss, Ibrahim; Atherton, Pamela J; Strand, Carrie A; Shah, Bijal; Webster, Jonathan; Bhatnagar, Bhavana; Flatten, Karen S; Peterson, Kevin L; Schneider, Paula A; Buhrow, Sarah A; Kong, Jianping; Reid, Joel M; Adjei, Alex A; Kaufmann, Scott H

Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancer

开发和验证一种液相色谱-质谱联用分析方法,用于定量分析雌激素受体阳性乳腺癌女性血浆中内多昔芬及其代谢物的Z-和E-异构体

Buhrow, Sarah A; Koubek, Emily J; Goetz, Matthew P; Ames, Matthew M; Reid, Joel M

Evaluation of analogs of mutacin 1140 in systemic and cutaneous methicillin-resistant Staphylococcus aureus infection models in mice

在小鼠全身性和皮肤耐甲氧西林金黄色葡萄球菌感染模型中评价mutacin 1140类似物

Ju, Min; Joseph, Thushinari; Hansanant, Nopakorn; Geng, Mengxin; Williams, McKinley; Cothrell, Andrew; Buhrow, Andrew Riley; Austin, Frank; Smith, Leif

Why not Y naught

为什么不是 Y naught

Jonika, Michelle M; Alfieri, James M; Sylvester, Terrence; Buhrow, Andrew Riley; Blackmon, Heath

Population Pharmacokinetics of Z-Endoxifen in Patients With Advanced Solid Tumors

晚期实体瘤患者中Z-恩多昔芬的群体药代动力学

Koubek, Emily J; Ralya, Andrew T; Larson, Thomas R; McGovern, Renee M; Buhrow, Sarah A; Covey, Joseph M; Adjei, Alex A; Takebe, Naoko; Ames, Matthew M; Goetz, Matthew P; Reid, Joel M

Drug discovery through the isolation of natural products from Burkholderia

通过从伯克霍尔德菌属中分离天然产物进行药物发现

Foxfire, Adam; Buhrow, Andrew Riley; Orugunty, Ravi S; Smith, Leif